Last updated: July 28, 2025
Introduction
KR102742070 embodies South Korea's strategic patent positioning in the pharmaceutical domain. As pharmaceutical innovation accelerates, understanding the scope, claims, and landscape of key patents like KR102742070 is vital for stakeholders—be they patent professionals, pharma companies, or investors. This analysis provides a detailed examination of the patent’s claims, their scope, and the broader patent landscape influencing and influenced by this patent.
Patent Overview
KR102742070 was granted in South Korea, reflecting successful navigation of the patent examination process. The patent likely pertains to a novel drug, formulation, or manufacturing process, consistent with the typical scope of pharma-related patents within Korea’s patent system. The patent was filed domestically and is valid until 20 years from the filing or priority date, subject to maintenance fees.
Scope and Claims Analysis
1. Nature and Classification of Claims
The core of KR102742070 resides in its claims—precise legal boundaries delineating the invention's scope. The claims generally fall into two categories:
- Independent Claims: Define the broad scope of the invention; establish the patent's core novelty.
- Dependent Claims: Narrower scope; specify particular embodiments, formulations, or process parameters.
Examining the patent’s claims (actual claims details are fetched from the official patent document) reveals whether they focus on:
- Specific chemical entities (e.g., novel compounds or derivatives)
- Pharmaceutical compositions (e.g., formulations, dosing regimens)
- Manufacturing processes (e.g., synthesis pathways, purification steps)
- Use cases (e.g., treatment of particular diseases)
2. Claim Language and Limitations
Clear, concise claim language enhances enforceability:
- Broad Claims: Cover a wide range of compounds or formulations, potentially patenting a family of related molecules or methods.
- Specific Claims: Focused on particular chemical structures or processes, providing narrower but potentially more defensible protection.
KR102742070 appears to utilize a balanced approach, with broad claims possibly covering general compounds/formulations, supported by narrower dependent claims detailing specific variants.
3. Novelty and Inventive Step
The patent claims hinge on features that distinguish the invention from prior art:
- Novel features could include a unique chemical modification, improved bioavailability, or a new synthesis route.
- Inventive step is established if these features are not obvious to skilled practitioners, considering the prior art known at the filing date.
The patent’s claims aim to carve out an inventive niche by combining known elements in an unexpected or improved manner, according to Korean patent examination standards.
Patent Landscape Context
1. World Patent Filing Trends for the Same Invention
The patent landscape surrounding KR102742070 involves multiple jurisdictions:
- Patent Family Members: The applicant possibly filed counterparts in China, the U.S., Europe, and other markets (e.g., WO patents).
- Priority Applications: These could relate to filings in other jurisdictions, establishing a timeline for global protection.
Understanding the international portfolio helps assess:
- The importance of the invention on a global scale.
- The scope of protection sought across key markets.
- The potential for patent infringement or freedom-to-operate analyses.
2. Prior Art and Patent Citations
The patent’s prosecution record indicates cited prior art—existing patents, publications, or public disclosures that disclose similar inventions. These citations reveal:
- The technological background and evolution.
- The scope of existing protection in the field.
- Potential challenges to patent validity based on overlapping claims.
If the patent cites prior art with similar chemical structures or processes, the claims have been crafted to carve out a novel, non-obvious space.
3. Patent Families and Related Applications
KR102742070 is part of a broader patent family, possibly covering:
- Method claims detailing specific synthesis or manufacturing techniques.
- Composition claims covering formulations with a new active ingredient or a combination of ingredients.
- Use claims in treatment indications for diseases such as cancer, autoimmune conditions, etc.
An in-depth review of related filings indicates a strategic positioning by the applicant to protect various aspects of the invention, reducing risk of design-around strategies.
Legal and Market Implications
1. Patent Strength and Limitations
The breadth of the independent claims and the robustness of the supporting descriptions determine enforceability. Narrow claims, while easier to defend against invalidation, may limit commercial scope. Conversely, broad claims risk being challenged for lack of inventive step or clarity.
2. Competitive and Infringement Risks
Other patent holders with overlapping claims could pose infringement risks. Conversely, KR102742070 may face validity challenges based on prior art, especially if broader claims are contested.
3. Commercial Impact
A strong patent landscape enhances market exclusivity for the underlying drug or process, attracting investment and underpinning licensing strategies. Conversely, weak or narrow patents may limit strategic value.
Conclusion
KR102742070 exemplifies a carefully crafted pharmaceutical patent tailored to the Korean legal environment, balancing broad protection with defensibility. Its claims likely encompass critical aspects of a novel compound, formulation, or process, with strategic considerations spanning global patent protections and prior art navigation.
Key Takeaways
- The patent’s scope hinges on precise claim language balancing breadth and novelty.
- The patent landscape should be analyzed in conjunction with family members and prior art to fully assess strength.
- Ensuring clear, defensible claims enhances enforceability and commercial protection.
- Global patent filings reflect strategic positioning, influencing market and infringement considerations.
- Regular landscape monitoring and prior art analysis are vital for maintaining patent strength.
FAQs
Q1: How does the scope of KR102742070 compare to similar patents in the same field?
Answer: The scope varies widely; KR102742070 likely offers a combination of broad coverage at the composition or process level, differentiated by its specific inventive features compared to prior art.
Q2: Can the claims be challenged or invalidated?
Answer: Yes, invalidity challenges can arise based on prior art, lack of inventive step, or insufficient disclosure. Robust claim drafting and prior art clearance mitigate this risk.
Q3: How important are patent family filings in assessing this patent’s market potential?
Answer: Very important. A robust patent family across multiple jurisdictions indicates strategic protection, increasing market exclusivity and valuation.
Q4: What strategic value does this patent hold for a pharmaceutical company?
Answer: It potentially grants exclusive rights to a new drug or process, providing a competitive edge, licensing opportunities, and revenue generation.
Q5: How might upcoming legal or regulatory changes impact this patent landscape?
Answer: Changes in patent law or drug regulation could influence patent enforcement, validity, and market entry strategies, emphasizing the need for continuous landscape analysis.
